On 2024-03-21, Kronos Bio, Inc. (KRON) announced earnings per share of $-0.43 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.51.
The next expected annoucement date for quarterly earnings is 2024-05-08, with an average estimated earnings per share of $-0.46 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-21 | 2023-12-31 | $-0.51 | $-0.43 |
| 2023-11-13 | 2023-09-30 | $-0.51 | $-0.54 |
| 2023-08-08 | 2023-06-30 | $-0.50 | $-0.52 |
| 2023-05-10 | 2023-03-31 | $-0.43 | $-0.46 |
| 2023-03-15 | 2022-12-31 | $-0.55 | $-0.56 |
| 2022-11-08 | 2022-09-30 | $-0.64 | $-0.57 |
| 2022-08-04 | 2022-06-30 | $-0.69 | $-0.59 |
| 2022-05-04 | 2022-03-31 | $-0.65 | $-0.65 |
| 2022-02-24 | 2021-12-31 | $-1.07 | $-1.13 |
| 2021-11-09 | 2021-09-30 | $-0.98 | $-0.61 |
| 2021-08-12 | 2021-06-30 | $-0.51 | $-0.53 |
| 2021-05-11 | 2021-03-31 | $-0.43 | $-0.48 |
| 2021-03-23 | 2020-12-31 | $-1.10 | $-0.44 |
| 2020-11-18 | 2020-09-30 | $-2.38 | $-4.00 |